本页面由Tiger Trade Technology Pte. Ltd.提供服务

Day One Biopharmaceuticals Inc.

11.42
-0.3000-2.56%
盘后11.420.00000.00%19:42 EST
成交量:192.24万
成交额:2,199.08万
市值:11.73亿
市盈率:-7.74
高:11.99
开:11.87
低:11.27
收:11.72
52周最高:13.20
52周最低:5.64
股本:1.03亿
流通股本:7,876.62万
量比:0.79
换手率:2.44%
股息:- -
股息率:- -
每股收益(TTM):-1.4748
每股收益(LYR):-1.0243
净资产收益率:-30.16%
总资产收益率:-18.57%
市净率:2.60
市盈率(LYR):-11.15

数据加载中...

公司资料

公司名字:
Day One Biopharmaceuticals Inc.
交易所:
NASDAQ
成立时间:
2018
员工人数:
184
公司地址:
1800 Sierra Point Parkway,Suite 200,Brisbane,California,United States
邮编:
94005
电话:
传真:
- -
简介:
Day One Biopharmaceuticals, Inc.于2018年11月在特拉华州注册成立为一家有限责任公司。作为一家商业化阶段的生物制药公司,该公司专注于开发针对儿童和成人疾病的首创或同类最佳药物。Day One采用搜索与开发战略来识别、收购和推进药物项目,其首个商业化产品是托沃拉非尼(tovorafenib)——一种口服、可穿透血脑屏障、高选择性的II型RAF激酶抑制剂。

董事

名称
职位
Jeremy Bender
Chief Executive Officer, President and Director
Julie Grant
Chair of the Board, Director and Co-Founder
Natalie Holles
Lead Independent Director
Dan Becker
Director
John Josey
Director
Michael Gladstone
Director
Saira Ramasastry
Director

股东

名称
职位
Jeremy Bender
Chief Executive Officer, President and Director
Charles York II
Chief Operating Officer, Chief Financial Officer and Secretary
Julie Grant
Chair of the Board, Director and Co-Founder
Samuel Blackman
Chief Medical Officer and Co-Founder